Page last updated: 2024-08-22

n-butylbenzenesulfonamide and Cancer of Prostate

n-butylbenzenesulfonamide has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baniahmad, A; Claessens, F; Matusch, R; Papaioannou, M; Roell, D; Schleich, S; Schubert, U; Tanner, T1
Baniahmad, A; Roell, D1

Reviews

1 review(s) available for n-butylbenzenesulfonamide and Cancer of Prostate

ArticleYear
The natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth.
    Molecular and cellular endocrinology, 2011, Jan-30, Volume: 332, Issue:1-2

    Topics: Androgen Receptor Antagonists; Cell Line, Tumor; Humans; Hydroxybenzoates; Male; Molecular Structure; Plant Extracts; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Sulfonamides

2011

Other Studies

1 other study(ies) available for n-butylbenzenesulfonamide and Cancer of Prostate

ArticleYear
NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.
    Investigational new drugs, 2010, Volume: 28, Issue:6

    Topics: Androgen Antagonists; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Humans; Ligands; Male; Phytotherapy; Plant Bark; Plant Extracts; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Binding; Protein Structure, Tertiary; Protein Transport; Prunus africana; Receptors, Androgen; Receptors, Progesterone; Sulfonamides; Transcription, Genetic

2010